Urinary transcript quantitation of CK20 and IGF2 for the non-invasive bladder cancer detection
Author:
Funder
European Regional Development Fund
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
http://link.springer.com/article/10.1007/s00432-017-2433-3/fulltext.html
Reference34 articles.
1. Babjuk M, Böhle A, Burger M et al (2016) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71:447–461. doi: 10.1016/j.eururo.2016.05.041
2. Breyer J, Otto W, Erben P et al (2017) In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival. Virchows Arch 470:267–274. doi: 10.1007/s00428-017-2064-8
3. Chau K, Rosen L, Coutsouvelis C et al (2015) Accuracy and risk of malignancy for diagnostic categories in urine cytology at a large tertiary institution: accuracy of urine cytology. Cancer Cytopathol 123:10–18. doi: 10.1002/cncy.21477
4. Choi W, Porten S, Kim S et al (2014) Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell 25:152–165. doi: 10.1016/j.ccr.2014.01.009
5. Chou R, Gore JL, Buckley D et al (2015) Urinary biomarkers for diagnosis of bladder cancer: a systematic review and meta-analysis. Ann Intern Med 163:922–931. doi: 10.7326/M15-0997
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Review on Bladder Cancer Diagnosis;Update on Bladder Cancer;2023-12-13
2. Liquid biopsy in urothelial carcinoma: Detection techniques and clinical applications;Biomedicine & Pharmacotherapy;2023-09
3. Evaluation of IGF2, KRT14, and KRT20 as Urinary Biomarkers in Patients with Bladder Cancer;Reports of Biochemistry and Molecular Biology;2023-02-01
4. Comprehensive optimization of urinary exfoliated tumor cells tests in bladder cancer with a promising microfluidic platform;Cancer Medicine;2022-12-25
5. The Role of Novel Bladder Cancer Diagnostic and Surveillance Biomarkers—What Should a Urologist Really Know?;International Journal of Environmental Research and Public Health;2022-08-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3